Protective Activity of Ingavirin® in Experimental Lethal Influenza Due to Pandemic Influenza Virus A (H1N1)v (Albino Mice)
Despite obvious success in the vaccine development and chemotherapy of influenza, it remains a poorly controlled infection leading to emergence of new pandemic variants of the virus with high morbidity and mortality. We investigated the protective activity of Ingavirin® against the lethal influenza...
Saved in:
| Main Authors: | V. V. Zarubaev, A. V. Garshinina, N. A. Kalinina, A. A. Shtro, S. V. Belyaevskaya, V. E. Nebolsin, O. I. Kiselev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01) -
In vivo Efficacy of Ingavirin® Against Pandemic A(H1N1/09)v Influenza Virus
by: L. N. Shishkina, et al.
Published: (2020-05-01) -
Investigation of Ingavirin® Antiviral Activity Against Season Influenza Virus A/H1N1 in MDCK Cell Culture
by: G. A. Galegov, et al.
Published: (2020-05-01) -
In vitro Efficacy of Ingavirin® against the Pandemic Influenza Virus A(H1N1/09)v
by: L. N. Shishkina, et al.
Published: (2020-05-01) -
In vitro Investigation of Ingavirin® Efficacy Against Influenza B Virus
by: S. YA. Loginova, et al.
Published: (2020-05-01)